An international multicentre controlled clinical trial to evaluate high dose RIFApentine and a QUINolone in the treatment of pulmonary tuberculosis http://www.ctu.mrc.ac.uk/research_areas/study_details.aspx?s=49

• Pays Botswana, Mozambique, South Africa, Zambia, Zimbabwe
• Organes Aucun
• Spécialités Aucune

The Effect of an Urban Sanitation Intervention on Child Health The purpose of this study is to determine the health impact of a basic sanitation intervention in Maputo, Mozambique.

• Pays Mozambique
• Organes Aucun
• Spécialités Aucune

Combination Antimalarials in Uncomplicated Malaria The purpose of this study is to study the efficacy of sulfadoxine-pyrimethamine on its own and compare this with efficacy of a new combination antimalarial therapy, either sulphadoxine-pyr...

• Pays Mozambique, South Africa, Swaziland
• Organes Aucun
• Spécialités Aucune

Artesunate Plus Sulfadoxine-pyrimethamine Pharmacokinetics, Efficacy, Gametocytes Carriage and Birth Outcomes in Pregnant Women With Malaria The main purpose of this study is to compare the drug levels of artesunate and sulfadoxine-pyrimethamine found in pregnant women with malaria to those drug levels found in non-pregnant wom...

• Pays Mozambique
• Organes Aucun
• Spécialités Aucune

A Randomised Efficacy Study of Combination Antimalarials to Treat Uncomplicated Malaria The purpose of this study is to compare the efficacy of sulfadoxine-pyrimethamine plus artesunate with that of sulfadoxine-pyrimethamine on its own for the treatment of uncomplicated malar...

• Pays Mozambique
• Organes Aucun
• Spécialités Aucune

Long-Term Follow-up of Children for a 2-Year Period to Confirm the Safety and Immunogenicity of GSK 257049 Vaccine The RTS,S/AS02A vaccine (or GSK 257049 vaccine), GSK Biologicals' candidate Plasmodium falciparum (P. falciparum) malaria vaccine is being developed for the routine immunization of infants...

• Pays Mozambique
• Organes Aucun
• Spécialités Aucune

A Randomised Efficacy Study of Combination Antimalarials to Treat Uncomplicated Malaria The purpose of this study is to determine the efficacy of sulfadoxine-pyrimethamine plus artesunate versus sulfadoxine-pyrimethamine alone in the treatment of uncomplicated malaria.

• Pays Mozambique
• Organes Aucun
• Spécialités Aucune

Study of AERAS-402 in Healthy Infants AERAS-402 will be given to infants of at least 16 weeks of age who have already been vaccinated with BCG to determine if AERAS-402 will increase protection of infants to tuberculosis.

• Pays Kenya, Mozambique, South Africa
• Organes Aucun
• Spécialités Aucune